Top brokers name 3 ASX shares to buy today

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three ASX shares brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Citi, its analysts have retained their buy rating and $41.00 price target on this gaming technology company’s shares. While the broker acknowledges that Aristocrat’s digital business is facing tough trading conditions, it believes its land-based business continues to perform well. So much so, the broker feels it could surprise the market with its earnings. The Aristocrat share price is trading at $34.80.

Metcash Limited (ASX: MTS)

A note out of Ord Minnett reveals that its analysts have upgraded this wholesaler’s shares to a buy rating with an improved price target of $5.00. This follows the release of a solid trading update at its annual general meeting this week which revealed that its sales have been strong early in FY 2023. The broker has lifted its earnings estimates to reflect this. The Metcash share price is fetching $4.14 this afternoon.

ResMed Inc. (ASX: RMD)

Analysts at Credit Suisse have retained their outperform rating and lifted their price target on this sleep treatment company’s shares to $40.00. This follows news that its rival Philips has been hit with another product recall. Credit Suisse suspects that this could lead to market share gains for ResMed and had bumped its estimates higher to reflect this. The ResMed share price is trading at $34.35 today.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here’s why the ResMed share price is charging higher today
• 3 ASX 300 healthcare share winners on Wednesday
• Here are the top 10 ASX 200 shares today
• Morgans names 3 more of the best ASX shares to buy in September
• 2 discounted ASX shares I’d buy now and one I wouldn’t touch: expert

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/cLuOHSl